These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8171540)
1. Cyclosporine levels predict the likelihood of rejection after simultaneous pancreas/kidney transplantation. Dawidson I; Lu C; Ar'Rajab A; Rossi P; Melone D; Wheeler D Transplant Proc; 1994 Apr; 26(2):534. PubMed ID: 8171540 [No Abstract] [Full Text] [Related]
2. Cyclosporine blood levels predict the likelihood of rejection and toxicity after simultaneous pancreas-kidney transplantation. Dawidson I; Ar'Rajab A; Lu C; Melone D Transplant Proc; 1995 Feb; 27(1):1324-6. PubMed ID: 7878901 [No Abstract] [Full Text] [Related]
3. Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation. Dawidson I; Ar'Rajab A; Lu C; Melone D; Provost D; Wheeler D Transplant Proc; 1994 Oct; 26(5):2757-8. PubMed ID: 7940868 [No Abstract] [Full Text] [Related]
4. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era? Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776 [No Abstract] [Full Text] [Related]
5. Eosinophiluria as an indicator of kidney-pancreas transplant rejection. Zamora J; Korb S; Bentt L; Allston C; Jonsson J; Currier C; Light JA Transplant Proc; 1993 Feb; 25(1 Pt 2):948-50. PubMed ID: 8442276 [No Abstract] [Full Text] [Related]
6. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results. Schulz T; Kapischke M; Busing M Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475 [TBL] [Abstract][Full Text] [Related]
7. Importance of cyclosporine dosage and blood levels in simultaneous pancreas and kidney transplant success. Cantarovich D; Dantal J; Hourmant M; Baatard R; Paineau J; Murat A; Soulillou JP Transplant Proc; 1992 Jun; 24(3):890-1. PubMed ID: 1604657 [No Abstract] [Full Text] [Related]
8. Cyclosporin monotherapy in pancreaticorenal transplantation. Ward RG; Gecim E; Bone JM; Bakran A; Sells RA Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547 [No Abstract] [Full Text] [Related]
9. Serum levels of pancreatic amylase and pancreas-specific protein as markers of pancreatic graft rejection episodes. Minakawa R; Brattström C; Tydén G; Tibell A; Pousette A; Bergström K Transplant Proc; 1995 Feb; 27(1):1329-30. PubMed ID: 7533379 [No Abstract] [Full Text] [Related]
10. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related]
11. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation. Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548 [No Abstract] [Full Text] [Related]
13. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine. Sutherland DE; Moudry-Munns KC; Gruessner A Transplant Proc; 1994 Oct; 26(5):2752-5. PubMed ID: 7940866 [No Abstract] [Full Text] [Related]
14. FK 506 induction and rescue therapy in pancreas transplant recipients. Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Weide LG; Frisbie K; Cushing KA; Jerius J; Radio SJ Transplant Proc; 1996 Apr; 28(2):991-2. PubMed ID: 8623492 [No Abstract] [Full Text] [Related]
15. Does suboptimal immunosuppression contribute to chronic rejection? Simić S; Djukanović L; Stojković D; Balgojević R; Sinthoić M; Lezaić V; Radivojević D Transplant Proc; 1995 Feb; 27(1):909-10. PubMed ID: 7879226 [No Abstract] [Full Text] [Related]
19. Limited utility of early trough cyclosporine level monitoring to predict the rate of acute rejection in the first three months after cardiac transplantation. Jennison SH; Wesp AG; McBride LR; Miller LW Transplant Proc; 1994 Oct; 26(5):2732-5. PubMed ID: 7940857 [No Abstract] [Full Text] [Related]
20. Cyclosporine therapy in pancreas transplantation. Davidson I; Lu C; Melone D; Risser R Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179 [No Abstract] [Full Text] [Related] [Next] [New Search]